Study of Selinexor Plus DRd for Newly Diagnosed Multiple Myeloma
Study of Selinexor Plus DRd for Newly Diagnosed Multiple Myeloma
Active, not recruiting · NCT04782687 · Registry updated 2025-01-16Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study of Selinexor Plus DRd for Newly Diagnosed Multiple Myeloma | Blood Protein Disorders, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, plasma cell myeloma, plasma cell neoplasm, vascular disorder, vascular hemostatic disease | Active, not recruiting | Phase 2 | 2025-01-16 | NCT04782687 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Karyopharm Therapeutics Inc | 25 |
| US Oncology Research | 5 |
10 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Arizona Oncology Associates, PC - HOPE | Tucson | United States | 4 |
| Maryland Oncology Hematology, P.A. | Columbia | United States | 9 |
| New York Oncology Hematology, P.C. | Albany | United States | 7 |
| Rocky Mountain Cancer Centers | Denver | United States | 26 |
| Texas Oncology, P.A. | San Antonio | United States | 1 |
| Texas Oncology, P.A. | Austin | United States | 1 |
| Texas Oncology, P.A. | Fort Worth | United States | 3 |
| Texas Oncology, P.A. | Tyler | United States | 2 |
| Virginia Cancer Specialists, PC | Gainesville | United States | 6 |
| Willamette Valley Cancer Institute and Research Center | Eugene | United States | 17 |